of the corresponding mutant mouse models. Translational approaches in development and medicine are relevant to gain understanding of the molecular events underlying clinical manifestations. Copyright © 2012 S. Karger AG, Basel Oral cavity and dental developmental anomalies are one aspect of rare diseases or syndromes. These diseases, which encompass about 8,000 different entities, affect 4 million people in France and almost 25 millions in Europe. Per se and definition they affect less than a person among 2,000 and 80% of them are genetically driven. Among more than 7,000 known syndromes, at least 900 have a dento/oro/facial phenotype and 750 display in their clinical synopsis a cleft lip/palate. This is understandable as the same genes and signaling pathways regulate palate, tooth development and the organogenesis of other systems. Considering the dual origin of teeth (the oral ectoderm for the enamel organ and the derived ameloblasts synthesizing the enamel matrix, and ectomesenchyme originating from the cephalic neural crest cells for the mesenchymal part of the tooth including pulp tissues, odontoblasts and the periodontium), orodental anomalies are very often present in syndromes involving
ectodermal derivatives like ectodermal dysplasias (EDs) where abnormalities of tooth number (missing teeth), shape (conical crown, taurodontic molars) or hard tissue structures (enamel hypoplasia) are part of the phenotype. These anomalies, associated to the clinical synopsis of these syndromes are increasingly identified as diagnostic and predictive traits.
The aim of this study is to increase the knowledge of genes involved in tooth development and anomalies in a syndromic context within the group of EDs through the analysis of their expression patterns during mouse odontogenesis, as well as in other ectodermal organs like salivary glands and vibrissae. Using a bioinformatic approach, we selected known genes involved in EDs within online databases (Online Mendelian Inheritance in Man, Orphanet [Aymé et al., 1998; Aymé, 2003] ) and the literature ( [Gorlin et al., 2001; Hennekam et al., 2010] , PubMed (http://www.ncbi.nlm.nih.gov/pubmed/)) with limited information about their expression pattern or role during odontogenesis. The online EURExpress in situ hybridization atlas (http://www.eurexpress.org; http://www.genepaint.org/) [Diez-Roux et al., 2011] was then used to identify genes showing detectable expression in tooth buds of embryonic day (E)14.5 mice. Five genes were thus selected, for which we performed a detailed analysis of their expression patterns by in situ hybridization at various stages of mouse development.
Materials and Methods

Sample Preparation
Mouse embryos/fetuses were collected at E12.5, E14.5, E16.5, and on the day of birth (hereafter referred to as E19.5), after natural matings between C57BL6 mice. For E14.5 and older samples, the whole head was embedded in OCT 4583 medium (Tissue-TEK, Sakura) and frozen on the surface of dry ice. E12.5 embryos were fixed overnight in 4% paraformaldehyde (pH 7.5, w/v) in PBS, cryoprotected by overnight incubation in 20% sucrose (w/v) in PBS, and cryoembedded as described above. Cryosections (Leica CM3050S cryostat) at 10 m were collected on Superfrost plus slides and stored at -80 ° C until hybridization. E12.5 and E14.5 samples were sectioned in a frontal plane, whereas other stages were sectioned sagittally.
Probe Synthesis
All probes were synthesized from PCR-generated DNA templates kindly provided by the EURExpress consortium (http:// www.eurexpress.org). The template sequences are given in online suppl. fig. 1 (www.karger.com/doi/10.1159/000342833).
DIG-labeled antisense riboprobes were transcribed in vitro by incubation for 2 h at 37 ° C using 1 g of the PCR product, 20 U RNA polymerase, 5 ! transcription buffer (Promega), 10 ! DIG RNA labeling Mix (Roche), 0.5 M DTT, 20 U RNAse inhibitor (Roche) in a 20-l volume. The following RNA polymerases (Sigma) were used: T7 polymerase ( Ercc3 and Evc2 probes), T3 polymerase ( Irf6 and Map2k1 probes) and SP6 polymerase ( Nfkbia probe). The reaction was stopped with 2 l EDTA (0.2 M , pH 8), and RNA was precipitated with 1 l yeast tRNA (10 mg/ml), 2.5 l LiCl (4 M ) and 75 l absolute ethanol, followed by an incubation for 30 min at -80 ° C and centrifugation at 12,000 rpm (30 min at 4 ° C). The pellet was washed with 0.5 ml ethanol (70%) and recentrifuged. The supernatant was discarded and the pellet was allowed to dry. The probe was then diluted in 20 l sterile H 2 O. The quality of the probe was verified by electrophoresis in a 1% agarose gel. If no smear was observed and the size was as expected, the probe was considered to be ready for use. The quantity of RNA was evaluated by a Nanodrop (ND-1000 Spectrophotometer, Labtech) and adjusted to 150 ng/ l in hybridization buffer, then stored at -20 ° C until use.
In situ Hybridization
Slides were allowed to thaw to room temperature (RT) for 2 h. Then they were post-fixed on ice in 4% paraformaldehyde (diluted in PBS) for 10 min and rinsed in PBS. The hybridization buffer was composed of 50% deionized formamide, 10% dextran sulfate, 1-mg/ml yeast tRNA, 1 ! Denhardt's solution, and 1 ! salt solution (0.195 M NaCl, 5 m M Tris pH 7.2, 5 m M NaH 2 PO 4 ؒ 1 H 2 O, 5 m M Na 2 HPO 4 ؒ 12 H 2 O, 5 m M EDTA pH 8). The probe was diluted in hybridization buffer at a concentration of 1 g/ml. The probe mix was denatured by a 10-min incubation at 70 ° C and placed on ice. An aliquot of 100 l was applied on each slide, which were covered by coverslips and allowed to hybridize overnight at 65 ° C in humidified chambers. The slides were then washed 2 times for 30 min at 65 ° C in 1 ! standard saline citrate (SSC), 50% formamide, 0.1% Tween-20, and 2 times for 30 min at RT in MABT buffer (1 ! MAB (Maleic acid buffer): 0.5 M maleic acid (Roche), 0.75 M NaCl, NaOH to ph 7.5 plus 0.1% Tween-20).
Probe detection was performed using antibodies and reagents from Roche. Slides were incubated for 1 h at RT with a blocking solution (20% goat serum, 2% blocking reagent in MABT). The anti-DIG antibody was diluted 1: 2,500 in blocking solution, and 200 l was added to each slide, which were covered by Parafilm and incubated overnight at 4 ° C. Slides were washed 5 times in MABT for 20 min and then 2 times for 10 min in NTMT buffer (100 m M NaCl, 100 m M Tris-HCl pH 9.5, 50 m M MgCl 2 ؒ 6 H 2 O, 0.1% Tween-20). An aliquot of 200 l of freshly prepared staining solution (3.5 l nitro-blue tetrazolium chloride (Roche), 3.5 l 5-bromo-4-chloro-3 -indolylphosphate p-toluidine salt (Roche) in NTMT buffer) was placed on each slide, covered by a Parafilm and incubated overnight in the dark at RT. The staining solution was changed every day and when signal was optimal the slides were rinsed 2 times during 5 min in NTMT buffer. The slides were further rinsed by PBS and water, allowed to dry overnight, and mounted in Coverquick 2000 mounting medium (Labonord).
Results
Selection of Candidate Genes
As described in the introduction section, 5 genes were selected on the basis of their involvement in rare human diseases and orodental anomalies (for an example, see fig. 1 ) [Vermeulen et al., 1994; Weeda et al., 1997; RuizPerez et al., 2000; Kondo et al., 2002; Courtois et al., 2003; McDonald et al., 2007; Vieira et al., 2007; Rutledge et al., 2010; Allanson et al., 2011] . Preliminary observation of in situ hybridization signals in the developing tooth buds and/or oral ectoderm of E14.5 mouse fetuses is shown in the EURExpress/GenePaint databases (http://www. eurexpress.org; http://www.genepaint.org/) [Diez-Roux et al., 2011] . A brief description of each gene is given hereafter, with table 1 providing additional information on the proteins encoded, mode of inheritance, and symptomatology of the corresponding syndromes or rare diseases.
Irf6 encodes an interferon regulatory transcription factor. It was recently reported that p63 and IRF6 interact epistatically in palatogenesis, and that IRF6 is a target of p63 in the midface [Moretti et al., 2010; Thomason et al., 2010] . Members of the IRF family are known to activate the canonical NF-B pathway [Hiscott, 2007] .
Nfkbia (formerly known as Ikba : NF-B inhibitor ␣ ) is a member of the NF-B inhibitor family. Mutations in this gene were discovered in autosomal dominant anhidrotic ED with T-cell immunodeficiency [Courtois et al., 2003; Lopez-Granados et al., 2008] .
Ercc3 , the excision repair cross-complementing 3/xeroderma pigmentosum B (ERCC3/XPB) DNA helicase, a subunit of the transcription factor TFIIH complex, is also involved in the DNA nucleotide excision repair mechanism.
Evc2 is a positive regulator of the Hedgehog signaling pathway, and encodes a cilium transmembrane protein located at the basal body of primary cilia. It is also found in the nucleus, where its function remains to be clarified [Blair et al., 2011] .
Map2k1 (formerly known as Mek1 or Mapkk1 ), is a member of the dual specificity protein kinase family which acts as a mitogen-activated protein (MAP) kinase kinase and is involved in many cellular processes such as proliferation, differentiation, transcriptional regulation and development. Developmental syndromes involving dysregulation of the RAS/MAPK pathway are referred to as RASopathies [Rauen et al., 2010] .
In situ Hybridization Expression Analysis
Tooth and Oral Cavity Development Table 2 provides a summary of the various transcript distributions observed in developing tooth tissues, which are described below.
Irf6 transcripts were detected in the epithelial compartment of the teeth: at E12.5 in the oral ectoderm and dental lamina ( fig. 2 A, B) ; at E14.5 throughout the whole enamel organ, especially in the future epithelial loop area ( fig. 2 C, D); at E16.5 in the outer dental epithelium, the stellate reticulum, and more intensely in the stratum intermedium and the epithelial loops ( fig. 2 E, F); and at E19.5 in the outer dental epithelium, the stratum intermedium, the preameloblasts, the inner dental epithelium and both epithelial loops ( fig. 2 G, H). Areas containing highly proliferative cells (such as the epithelial loops or stem cell niche) were strongly labeled.
The Nfkbia probe labeled the oral ectoderm and dental lamina at E12.5 ( fig. 3 A, B) . At E14.5 the transcripts were scattered in the enamel organ of all teeth, with a particularly strong labeling of the enamel knot ( fig. 3 C, D) . The epithelium lining the palatal shelves was labeled prior to contact (data not shown). At E16.5 at the bell stage, the epithelial loops, inner dental epithelium and outer dental epithelium were most prominently labeled ( fig. 3 E, F). At E19.5 the transcripts were localized in the inner and outer dental epithelium, in the preameloblast area and in the epithelial loops (for the second molars), as well as in odontoblasts ( fig. 3 G 
, H).
Ercc3 expression was detected in the oral ectoderm at E12.5 and E14.5 (as seen on cap stage lower incisors fig. 4 A and data not shown). Ercc3 was expressed in the enamel organ and more weakly in the mesenchyme both in molar and incisor at E14.5 ( fig. 4 A) and E16.5 ( fig. 4 B and data not shown). The in situ hybridization signal was quite faint and dotty. At E19.5 the labeling was clearly asymmetric and, for the incisors, was higher in the labial area within the epithelial loop and facing mesenchyme. The preameloblasts were also labeled ( fig. 4 C) . The most differentiated epithelial cells were devoid of signal. At E19.5, the signal was visible both in the first Fig. 1 . An orodental phenotype observed in an ectodermal dysplasia (ED), here hypohidrotic ED shown as an example, includes missing teeth (hypodontia, oligodontia), microdontia and abnormalities of tooth shape (conical teeth). The anomalies of tooth number, shape and size are associated and represent a continuum of anomalies. and second molars in the inner dental epithelium, the preameloblasts and the epithelial loops (data not shown).
In the second molars it was widespread in the mesenchyme whereas it was more focused to the base of the cusps and the area facing the epithelial loops for the first molars. In the inner dental epithelium the signal was clearly visible in the basal region of cells in contact with the basement membrane. Evc2 was expressed in the oral ectoderm and the dental lamina at E12.5 (data not shown). At E14.5 the signal was observed in the molar cap both in the enamel organ and within the ectomesenchyme ( fig. 4 D) . The molar gubernaculum was also labeled. At E16.5 cartilaginous tissues including Meckel cartilage were strongly expressing this gene (data not shown). A faint signal was detected in the incisor and molar mesenchyme. At E19.5 the transcripts were detected in the mesenchyme and in the preodontoblast/odontoblast layers (data not shown).
Map2k1 was expressed in the oral ectoderm and the epithelial dental lamina at E12.5 (data not shown). The signal was then apparent both in the epithelial and mesenchymal compartments of the cap stage teeth at E14.5 ( fig. 4 E and data not shown) . At E16.5, in addition to cartilaginous areas, the transcripts were detected in the mesenchyme and the epithelial inner, outer and loop areas for both the incisors and molars ( fig. 4 F and data not shown) . At E19.5 the transcripts were mainly mesenchymal ( fig. 4 G) . 
Salivary Glands and Vibrissae
The expression patterns of Irf6 , Nfkbia , Ercc3 , Evc2 , and Map2k1 are further illustrated in 2 organs in which specialized ectoderm-derived tissues are developing, the salivary (submandibular) glands and the vibrissae follicles ( fig. 5 ). With the exception of Evc2 , all genes displayed distinct expression in the epithelial cell component of the developing salivary glands ( fig. 5 A- 
E). Irf6
and Map2k1 were particularly strongly expressed in the epithelial layer of the vibrissae follicle shafts whereas Nfkbia displayed weaker discontinuous labeling and Ercc3 as well as Evc2 no obvious expression in this epithelial compartment ( fig. 5 F-J H first and second molars). All section planes are coronal (frontal), except for E-H (sagittal). DL = Dental lamina, DP = dental papilla, EL = epithelial loop, EO = enamel organ, Gu = gubernaculum, IDE = inner dental epithelium, In = incisor, M1 = first molar, M2 = second molar, Md = mandible, ODE = outer dental epithelium, PreAm = preameloblasts, SI = stratum intermedium, SR = stellate reticulum, To = tongue. Fig. 3 . In situ hybridization analysis of Nfkbia expression in the developing teeth and oral cavity. The selected sections show the mandibular incisor dental lamina ( A ), posterior tongue/pharyngeal region and molar dental lamina ( B ) at E12.5, the lower incisors ( C ) and the first molar caps ( D ) at E14.5, the lower incisor ( E ) and the first mandibular molar ( F ) at E16.5, and the lower incisor ( G ) and first and second molars ( H ) at E19.5. All section planes are coronal, except for E-H , which are sagittal. DL = Dental lamina, EK = enamel knot, EL = epithelial loop, IDE = inner dental epithelium, La = labial, Lin = lingual, M1 = first molar, M2 = second molar, Md = mandible, ODE = outer dental epithelium, PreAm = preameloblasts, To = tongue.
Discussion
Tooth development is embedded within craniofacial development. It originates from pluripotent cephalic neural crest cells which migrate towards the first pharyngeal arch, triggering in combination with mesodermal cells the development of many craniofacial structures [Cobourne and Mitsiadis, 2006; Knight and Schilling, 2006; Noden and Schneider, 2006] . Odontogenesis leads to specific crown and root morphogenesis for each type of tooth (incisors and molar for the mouse), to enamel organ histomorphogenesis and to terminal cytodifferentiation of odontoblasts, ameloblasts and cementoblasts. Evolutionary study of mammals is often focused on detailed analysis of tooth shapes. Molecular patterning may influence dental evolution via differences in gene expressions correlated with morphological variations [Jernvall et al., 2000; Salazar-Ciudad and Jernvall, 2002; Plikus et al., 2005] . The continuous and progressive stages of odontogenesis have classically been divided into the dental lamina, placode, bud, cap and bell stages, root formation and tooth eruption. Tooth development is a dynamic pro- cess mediated by epithelio-mesenchymal interactions between ectomesenchymal cells originating from cephalic neural crest cells and the first pharyngeal arch ectoderm [Peters and Balling, 1999; Thesleff and Aberg, 1999; Tucker and Sharpe, 1999; Thesleff, 2003a; Tucker and Sharpe, 2004] . These cells contribute to the formation of the dental mesenchyme, the dental pulp, odontoblasts, dentine matrix, cement and periodontium [Chai et al., 2000; Miletich and Sharpe, 2004] . Extracellular matrix (i.e. basement membrane, predentine, dentine) participates in odontogenesis either as a substrate for interaction with receptors of the plasma membrane, or as a putative reservoir of endocrine or paracrine factors like peptide growth factors. Tooth morphogenesis is under strict genetic control and the participating genes are being discovered at an increasing speed. By 2008, more than 300 of these genes had been listed in the database created by P. Nieminen (Helsinki University, Finland) gathering expression patterns at various stages of odontogenesis from worldwide laboratories (http://bite-it.helsinki.fi) [Nieminen et al., 1998 ]. Developmental dental anomalies may exist in isolation or may be associated with extraoral clinical manifestations in syndromes, and can be of genetic origin or due to the action of teratogens [Alaluusua et al., 1999; Berdal, 2003; Koch, 2003; Weerheijm, 2003; Alaluusua, 2006; Alaluusua and Lukinmaa, 2006] . They are correlated to specific genetic and developmental biology events [BlochZupan, 2004; Bloch-Zupan et al., 2012] such as the embryonic origins of dental cells, the patterning of the dentition, the defined location of tooth development, tooth identity, specific morphogenesis, histogenesis, terminal differentiation of odontoblasts and ameloblasts, dentine and enamel matrix synthesis followed by mineralization, root and periodontium formation and eruption of teeth [Salazar-Ciudad and Jernvall, 2002; Thesleff, 2003a Thesleff, , b, 2006 . Any interference with these developmental processes can lead to clinical anomalies and defects [Thesleff, 2000 [Thesleff, , 2006 Aldred et al., 2003; MacDougall, 2003] and some may even lead to tumors from dental epithelial cells [Papagerakis et al., 1999] . EDs are disorders characterized by alterations in 2 or more ectodermal structures affected in the following decreasing order of frequency: hair, teeth, nails, sweat glands, salivary glands and any other ectodermal appendage [Visinoni et al., 2009] . So far, identification of a wide variety of genes has led to the molecular characterization of around 30% of EDs and to a reconsideration of their clinical classification. The genes selected in the present study are involved in various rare diseases belonging to the ED spectrum: IRF6 in Van der Woude syndrome [Kondo et al., 2002] , non-syndromic cleft lip/palate [Vieira et al., 2007; Desmyter et al., 2010; Rutledge et al., 2010] , hypodontia [Vieira et al., 2007] ; NFKBIA in ED with immune deficit [Courtois et al., 2003; Lopez-Granados et al., 2008] ; ERCC3 in xeroderma pigmentosum [Bootsma et al., 1995] and trichothiodystrophy [Weeda et al., 1997] ; EVC2 in Ellis-van Creveld syndrome [Galdzicka et al., 2002] ; MAP2K1 [RodriguezViciana et al., 2006] in cardiofaciocutaneous syndrome.
While the same genes are indeed involved in different diseases with overlapping phenotypes, it is also interesting to note that mutations in different genes may account for similar diseases. Cardiofaciocutaneous syndrome, for example, is caused by gain of function mutations in BRAF (7q34), KRAS2 (12p12.1), MEK2 (7q32) and MAP2K1 (15q21) [Allanson et al., 2011] ; Ellis-van Creveld syndrome is caused by mutations in EVC and EVC2 (4p16.2) [Ruiz-Perez et al., 2003] .
Our in situ hybridization expression data confirmed the transcription of the selected murine genes in different tissues/organs of ectodermal origin (teeth, salivary glands, vibrissae). However, Nfkbia, Ercc3, Evc2, and Map2k1 signals were also present in the ectomesenchymal compartments of the tooth germs. Indeed, EDs are groups of conditions presenting similar ectodermal signs, but the associated defects may primarily concern mesenchymal structures, for example bone in Ellis-van Creveld syndrome. Expression of Irf6 was previously described [Kondo et al., 2002; Knight et al., 2005; Blackburn et al., 2012] as occurring in the ectoderm covering the facial processes during the formation of the lip, the primary palate, and the secondary palate from E14.5 to E15 mouse embryos. Recently, information was provided about the localization of Irf6 transcripts between E10.5 and E18.5 during odontogenesis [Blackburn et al., 2012] . No precise description at the tissular level (outer dental epithelium, stratum intermedium, inner dental epithelium, preameloblasts) was given, however. For example the strong signal and localization within the future epithelial loop area of the cap, then bell stage teeth (i.e. the proliferating area), were not described.
MAP2K1 immunolocalization was described in human third molar tooth germs enucleated for orthodontic reasons at the early crown mineralization stage. Strong reactivity was observed in inner dental epithelium, and weak to moderate staining was visible in outer dental epithelium, stratum intermedium and stellate reticulum [Kumamoto et al., 2004] . These results are in agreement with the expression pattern described for Map2k1 in the present study except for the localization within the stel-late reticulum and stratum intermedium sometimes difficult to assess.
The expression patterns of Nfkbia , Ercc3 and Evc2 during odontogenesis had never been reported previously. The expression patterns described herein are consistent in timing and localization with the known dental anomalies (hypodontia/oligodontia, smaller and conical teeth, enamel hypoplasia) occurring in patients [Clauss et al., 2008; Gros et al., 2010] . Disruption of molecular/biological events at early stages of odontogenesis (dental lamina, transition bud to cap stage) are linked to missing teeth, at the cap stage to anomalies of tooth shape and size, at the bell stage and terminal cytodifferentiation with anomalies of tooth structure (dentine and enamel). It is also interesting to notice that cleft lip and palate are symptoms present in the clinical synopsis of Ellis-van Creveld and Van der Woude syndromes and that the corresponding genes (Evc2 and Irf6) are expressed in the palatal medial epithelial edge and seam (data not shown).
Mouse models generated by targeted gene mutations often mimick the phenotypes encountered in corresponding rare human diseases [Fleischmannova et al., 2008] . The Ercc3 knock-in mice [Andressoo et al., 2009] recapitulate the UV sensitivity typical for xeroderma pigmentosum, but fail to show overt Cockayne syndrome features, i.e. no observation or mention of an orodental phenotype was described for the mutant mice. Evc nullmutant mice develop an EVC-like syndrome, including short ribs, short limbs and dental abnormalities [RuizPerez et al., 2007] . Mutants showed small dysplastic incisors, and conical lower molars. The size of the first molar was reduced, and enamel defects were visible. Null-mutant mice for Irf6 have abnormal skin, limb and craniofacial development [Ingraham et al., 2006] . Histological and gene expression analyses indicate that the primary defect is in keratinocyte differentiation and proliferation. The cleft palate 1 (Clft1) mutant mouse also displays a mutation in Irf6 (Van der Woude syndrome mutation) [Ingraham et al., 2006; Stottmann et al., 2010] . The mandible in the Irf6 mutant was smaller with a narrower angle than in the wild-type, and the snout was also shorter with cleft palate [Ingraham et al., 2006] . Protruding incisors were described in Irf6 mutant mice, pointing toward an important role of IRF6 in tooth epithelial invagination [Blackburn et al., 2012] . The disruption of the murine Map2k1 gene leads to an embryonically lethal phenotype at mid-gestation from an abnormal placenta development and vascularization [Bissonauth et al., 2006] . Ikbia -deficient mice show skin defects and die at day 9 post-natally with severe widespread dermatitis and increased levels of TNF-␣ mRNA in the skin [Klement et al., 1996] . These mice develop a severe hematological disorder [Rupec et al., 2005] ; however, no features reminiscent of ED and dental abnormalities observed in human patients with NFKBIA mutations were described in mice.
Conclusions
Orodental anomalies of transgenic mouse models are often insufficiently described, thus making it difficult to fully compare mouse and human disease phenotypes. However, the mouse orodental anomalies quite frequently reflect the human counterpart malformations with regard to the clinical synopsis of syndromes, confirming the informative role of these models to study tooth development and anomalies. This study described the expression pattern of murine homologs of human genes involved in tooth development and disease, focusing on the ED spectrum. It reinforces the utility of translational approaches in development and medicine to gain understanding of the molecular events underlying the clinical manifestations, especially the orodental anomalies accompanying these rare diseases.
